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Abstract
To investigate the clinical characteristics and risk factors for miscarriage of intrauterine normal pregnancy of patients with a
heterotopic pregnancy (HP) after treatment.
This was a retrospective study of medical records from CHA Bundang Medical Center. Sixty-four patients who were diagnosed
with a HP between February 2006 and July 2017 were included in this study. All analyses were performed using SAS software,
version 9.4 (SAS Institute, Inc., Cary, NC). P values< .05 were considered statistically signiﬁcant.
Forty-eight patients had tubal ectopic pregnancies (EP), 10 patients had cornual EPs, 1 patient had a cesarean section scar EP, 4
patients had an ovarian EP, and 1 patient had bilateral tubal EP. Among the 64 patients, 14.1% (9/64) miscarried before 10 weeks of
gestation after management. Mean gestational age (GA) at treatment was 5.97±0.50 weeks and 6.80±1.04 weeks for miscarriage
and nonmiscarriage group, respectively (P= .008). Signiﬁcant differences were observed between 2 groups in terms of
ultrasonographic features at the time HP was diagnosed (P= .040) Logistic regression models indicated that gestational age at
treatment showed signiﬁcant differences between 2 groups (OR: 0.003, 95% CI: 0.001–0.604).
Immediate management after diagnosis could expect favorable prognosis of HP. GA at treatment was the only independent risk
factor for miscarriage in patients with HP regardless of treatment methods.
Abbreviations: ART= assisted reproductive technology, COH-TI= controlled ovarian hyperstimulation and timed intercourse, EP
= ectopic pregnancy, GA = gestational age, GS = gestational sac, hCG = human chorionic gonadotropin, HP = heterotopic
pregnancy, IUI = intrauterine insemination, IUP = intrauterine pregnancy, IVF = in vitro fertilization, KCL = potassium chloride, MTX =
methotrexate, TVS = transvaginal ultrasonography, YS = yolk sac.
Keywords: fetal heart beat, gestational age, heterotopic pregnancy, miscarriage, outcome1. Introduction
Heterotopic pregnancy (HP) is deﬁned as the simultaneous
existence of intrauterine pregnancy (IUP) and extrauterine
ectopic pregnancy (EP). The incidence of HP in patients with a
natural pregnancy is about 1 in 10,000 to 1 in 50,000
pregnancies.[1] However, because assisted reproductive technol-
ogies (ARTs) are widely used, the incidence of HP is greater,Editor: Yan Li.
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1ranging from 1 in 100 to 1 in 3600 pregnancies, with a prevalence
of 0.5% to 1% among all pregnancies.[2]
The early diagnosis and treatment of HP are essential since
rupture during EP causes life-threatening complications such as
hypovolemic shock and maternal death. However, the diagnosis
of HP in the early stage is difﬁcult, since a visible IUP on
transvaginal sonography (TVS) can easily lead clinicians to
ignore the existence of a possible EP. Moreover, an EP might be
too small to detect on TVS in the early stage, and b-human
chorionic gonadotropin (hCG) measurements are not helpful to
detect HP, although they are useful to distinguish an EP from a
normal, early IUP.
The primary treatment goal of HP is successful removal of an
EP while preserving a normal IUP. The treatment options of HP
may be surgical, medical, or expectant. If the patient does not
have a hemoperitoneum or symptoms such as abdominal pain,
and ﬁndings that are seen on serial ultrasound do not worsen,
expectant treatment may be performed. However, if the patient’s
condition is hemodynamically and symptomatically unstable, the
EP must be removed through surgical treatment such as
laparotomy or laparoscopy. In patients with an unruptured
cornual or cesarean section scar EP, ultrasound-guided local
injection of potassium chloride (KCL), methotrexate (MTX), or
aspiration of the gestational sac (GS) can be considered. The early
diagnosis and management of HP can reduce severe maternal
morbidity and mortality, but whether the early treatment of EP
has favorable effects on the outcomes of IUP has not been
Table 1
Basic characteristics of patients.
Variables Population (n=64)
Age, mean±SD, yr 33.0±3.0
BMI, mean±SD, kg/m2 21.7±2.8
Parity, primiparous, n (%) 51 (80)
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diagnosis, treatment, and outcomes of patients with an HP, but
most of these studies are case reports.[1–3]
The purpose of this study was to evaluate the clinical
characteristics of patients with HP, the risk factors of miscarriage
of IUP after the treatment of HP.Abortion history, n (%) 24 (37.5)
Gestational age at diagnosis, mean±SD, wk 6.5±0.8
Method of pregnancy, n (%)
Natural pregnancy 2 (3)
COH-TI 4 (6)
IUI 2 (3)
IVF 56 (88)
Number of transferred embryos, n (%)
2 11 (11/56, 19.6%)
3 30 (30/56, 53.6%)
≥4 15 (30/56, 26.8%)
History of gynecological surgery, n (%) 21 (33)
Myomectomy 4
Ovarian cystectomy 8
Salpingectomy 5
Tuboplasty 2
Tubal ligation 1
Diagnostic laparoscopy 1
Previous history of ectopic pregnancy, n (%) 10 (16)
Right tube 3
Left tube 6
Bilateral tube 1
BMI=body mass index, COH-TI= controlled ovarian hyperstimulation and timed intercourse, IUI=
intrauterine insemination, IVF= in vitro fertilization, SD= standard deviation.2. Methods
This study was a retrospective study of 64 patients who were
diagnosed with HP between February 2006 and July 2017 at
Bundang CHA Medical Center, Korea. Ethical approval was
obtained from the institutional review board of Bundang CHA
Medical Center (CHAMC 2018-02-024).
Sixty-four patients whowere diagnosed withHPwere included
in this study. Two patients became pregnant naturally and 62
patients became pregnant using an ART. The ARTs included
controlled ovarian hyperstimulation and timed intercourse
(COH-TI), intrauterine insemination (IUI), and in vitro fertiliza-
tion (IVF). IUP was determined in patients in whom a yolk sac
(YS) and/or fetal pole was detected in an intrauterine GS using
TVS. We retrospectively analyzed the basic characteristics of the
study group, including age, body mass index, parity, abortion
history, EP history, gynecological surgery history, gestational age
(GA) at the time HP was diagnosed, ultrasonography ﬁndings,
clinical features, EP site, treatment method of HP, and pregnancy
outcomes, including miscarriage immediately after treatment.
A miscarriage after treatment was deﬁned as an abortion
before a GA of 10 weeks, excluding those with a vanishing
intrauterine twin pregnancy after treatment. HP was diagnosed
via transvaginal or abdominal ultrasonography. Patients had
routine elective ultrasonography within 5 to 6 weeks of gestation.
Those with symptoms such as abdominal pain or vaginal
bleeding underwent emergent ultrasonography. Ultrasonography
was performed to evaluate the status of the intrauterine fetus,
including single or twin pregnancy fetuses, presence of a YS or
fetal heart activity, EP site, and presence of a hemoperitoneum.
Treatment was performed within 24hours if HP was suspected.
The operation time was calculated as the time from when a skin
incision was made to the time when the skin was closed, and the
anesthesia time was calculated as the time from when the patient
ﬁrst underwent an anesthetic procedure to when the patient
awoke from anesthesia.
For the statistical analyses, the Chi-square test or Fisher exact
test was used for categorical variables and the 2-sample t test or
Wilcoxon rank sum test was used for continuous variables.
Logistic regression with the penalized maximum likelihood
estimation method was used to estimate odds ratios with 95%
conﬁdence intervals for risk factors of miscarriage after the
treatment of HP. All analyses were performed using SAS
software, version 9.4 (SAS Institute, Inc., Cary, NC). All P
values <.05 were considered statistically signiﬁcant.3. Results
The basic characteristics of patients were investigated. Twenty-
one (33%) patients had a history of gynecological surgery and 8
(12.5%) patients had undergone tubal surgery. Ten (16%)
patients had a history of EP among study population (Table 1).
Among the 64 patients in this study, 19 patients had a normal
twin pregnancy. Among those with a twin IUP, a patient had a
miscarriage and 3 patients had a vanishing twin after treatment
that resulted in a single-born live birth. The location of the EPwas2determined with TVS with conﬁrmation via laparoscopy in most
of the cases. Forty-eight patients had tubal pregnancies (Fig. 1),
10 patients had cornual pregnancies (Fig. 2A), a patient had a
cesarean section scar pregnancy (Fig. 2B), 4 patients had ovarian
pregnancies (Fig. 3A) and all patients underwent laparoscopic
operation (Fig. 3B).
At the time of diagnosis, 1 patient had only a GS; 10 patients
had a GS, YS, and absence of fetal heart activity; and 53 patients
had fetal heart activity of the IUP that was seen on ultrasonogra-
phy (Table 2).
We investigated the management of HP (Table 3). Among
those with a tubal HP, 47 patients underwent laparoscopic
salpingectomy, 1 patient underwent exploratory salpingectomy,
and 1 patient underwent ultrasound-guided GS aspiration. In
addition, among 10 patients with a cornual HP, 5 patients
underwent laparoscopic cornual resection, 4 patients received an
ultrasound-guided KCL injection, and 1 patient received an
ultrasound-guided MTX injection after spontaneously miscarry-
ing her IUP fetus. One patient with a cesarean section scar HP
miscarried an EP fetus soon after treatment.
Four patients with an ovarian HP underwent laparoscopic
excision of an ovarian mass.
Among the 64 patients, 9 miscarried before 10 weeks’
gestation, within 3 weeks of surgery (Table 4). Twenty-nine
pregnant women had a live birth at our institution, and 23
patients delivered babies at full term. None of the HP babies who
were born at our hospital had major anomalies. The risk factors
of miscarriage after the treatment of HP were compared between
the miscarriage (n=9) and nonmiscarriage group (n=55)
(Table 5). There were no signiﬁcant differences in terms of
history of EP, method of pregnancy, type of HP, method of
management, operation time, and anesthesia time. However,
signiﬁcant differences were observed between the 2 groups in
Figure 2. (A) Sonographic feature of heterotopic pregnancy with right cornual ectopic pregnancy. (B) Sonographic feature of heterotopic pregnancy with cesarean
section scar ectopic pregnancy.
Figure 1. (A) Sonographic feature of normal intrauterine pregnancy of heterotopic pregnancy and (B) right tubal pregnancy in same patient.
Figure 3. (A) Sonographic feature of heterotopic pregnancy with right ovarian ectopic pregnancy. (B) Laparoscopic ﬁnding of heterotopic pregnancy with ruptured
right ovarian ectopic pregnancy.
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Table 2
Clinical features at the time of diagnosis.
Variables Population (n=64)
Intrauterine, multiple pregnancy,
n (%)
19 (29.7)
Miscarriage after treatment 1
Vanishing twin after treatment 3
EP type
Unilateral tubal EP, n (%) 48 (75)
Rupture before diagnosis 11
Mean GA at the time of
rupture, mean±SD, wk
7.0±0.9
Mean GA at the time of
diagnosis, mean±SD, wk
6.8±1.1
Miscarriage of the IUP fetus 7
Bilateral tubal EP, n (%) 1 (1.6)
Rupture before diagnosis 0
GA at the time of
diagnosis, wk
6.1
Miscarriage of the IUP fetus 0
Cornual EP, n (%) 10 (15.6)
Rupture before diagnosis 4
Mean GA at the time of
rupture, mean±SD, wk
6.4±1.1
Mean GA at the time of
diagnosis, mean±SD, wk
6.3±0.9
Miscarriage of the IUP fetus 2
Ovarian EP 4 (6.3)
Rupture before diagnosis 4
Mean GA at the time of
rupture, mean±SD, wk
6.7±0.7
Miscarriage of the IUP fetus 0
Cesarean section scar EP 1 (1.6)
Rupture before diagnosis 0
GA at the time of diagnosis 5.3
Miscarriage of the IUP fetus 0
Sonographic features of the
IUP at diagnosis
Only GS (miscarriage) 1 (0)
Y-sac (+), fetal heart beat
() (miscarriage, %)
10 (4, 40)
Fetal heart beat
(miscarriage, %)
53 (5, 9.4)
Clinical manifestation
Symptomatic abdominal
pain due to ectopic site
rupture (miscarriage, %)
19 (1, 5.3)
Mean GA at rupture, wk 6.8
EP= ectopic pregnancy, GA=gestational age, GS=gestational sac, IUP= intrauterine pregnancy.
Table 4
Neonatal outcomes of heterotopic pregnancy.
Variable Patients (n=64)
Obstetrical outcomes, n (%)
Missed abortion after treatment (before 10 wk) 9 (14.1)
Within 1 wk 5/9 (55.6)
Within 2 wk 3/9 (33.3)
Within 3 wk 1/9 (11.1)
Born at our institution 29
Term delivery 23
Preterm delivery (twin) 6
Premature rupture of the membrane 1
Preterm labor without preterm delivery 4
Delivery mode
Vaginal delivery 11
Cesarean section 18
Table 3
Treatment of ectopic pregnancy.
Variables Patients (n=64)
Tubal pregnancy, n (%) 49 (76.6)
Laparoscopic salpingectomy, n (%) 47/49 (95.9)
Exploratory salpingectomy, n (%) 1/49 (2.0)
US-guided GS aspiration, n (%) 1/49 (2.0)
Cornual pregnancy, n (%) 10 (15.6)
Laparoscopic cornual resection, n (%) 5/10 (50)
US-guided KCL injection, n (%) 4/10 (40)
US-guided MTX injection after miscarriage
of the IUP fetus, n (%)
1/10 (10)
Ovarian pregnancy, n (%) 4 (6.3)
Laparoscopic ovarian mass excision, n (%) 4/4 (100)
Cesarean section scar pregnancy, n (%) 1 (1.6)
Observation, n (%) 1/1 (100)
GS=gestational sac, IUP= intrauterine pregnancy, KCL=potassium chloride, MTX=methotrexate,
US=ultrasound.
Na et al. Medicine (2018) 97:37 Medicineterms of ultrasonographic features at the time HP was diagnosed
(P= .039) and GA at treatment (P= .008). However, when we
performed logistic regression, GA at treatment was the only
independent risk factor for miscarriage in patients with HP
regardless of treatment methods (OR: 0.003, 95% CI: 0.001–
0.604).Placental abruption 1
Newborn anomaly 4
Hydronephrosis 2
Polydactyly 1
ASD, PS 1
NICU admission 3
ASD= atrial septal defect, NICU=neonatal intensive care unit, PS=pulmonary stenosis.4. Discussion
EP is deﬁned as an abnormally implanted pregnancy outside the
intrauterine cavity, and occurs in 1% to 2% of all pregnancies.
The most frequent EP site is the ampulla portion of the fallopian
tube.[4] HP is the simultaneous existence of a normal IUP and EP
and is a rare condition in patients with a naturally conceived4pregnancy. However, with the widespread use of ART, especially
in those with an embryo transfer, the incidence of HP is
increasing. The EP site in those with an HP may be the fallopian
tube, cornual area of the uterus, cesarean section scar, cervix,
ovary, and other peritoneal spaces. Because most studies reported
data on small sample sizes or case reports, the most common
ectopic site of HP has not been well established, but tubal EP in
those with an HP is considered the most frequent site, similar to
those with EP alone.[5,6]
In our study, 62 patients conceived with ART, including 56
who conceived via IVF. In patients with a natural pregnancy, it
was difﬁcult to suspect HP until symptoms such as abdominal
pain, vaginal bleeding, and rectal tenesmus occur. In addition,
measurement of serum hCG is not useful for detecting HP, and
ultrasonography in the early gestational stage is not helpful for
diagnosing HP. However, in patients with an ART-conceived
pregnancy, the diagnosis can be made and treatment can be
performed earlier because there is an increased risk of HP.
Table 5
Risk factors of miscarriage after the treatment of patients with heterotopic pregnancy.
Variables Miscarriage (n=9) Nonmiscarriage (n=55) P OR (95% CI)
Age, y 34.2±2.3 33.2±3.5 .386 1.10 (0.89, 1.37)
BMI, kg/m2 22.3±2.0 21.6±2.9 .486 1.09 (0.86, 1.40)
Parity (primiparous) 1 (11.1) 12 (21.8) .556 0.45 (0.05, 3.94)
Abortion history, % 3 (33.3) 21 (38.2) .644 0.81 (0.18, 3.59)
Previous ectopic pregnancy 1 (11.1) 9 (16.4) .426 0.64 (0.07, 5.76)
Previous gynecological surgery 4 (44.4) 14 (25.5) .076 2.34 (0.55, 9.97)
Multiple intrauterine pregnancies 1 (11.1) 18 (32.7) .260 0.26 (0.03, 2.21)
Pregnancy method 1.00
Natural pregnancy 0 2 (3.6) Ref.
IVF 9 (100.0) 47 (85.8) 1.00 (0.02, 43.99)
IUI 0 2 (3.6) 1.00 (0.01, 192.22)
COH-TI 0 4 (7.3) 0.56 (0.00, 78.37)
Sonographic features (IUP) .040
GS only 0 1 (1.82) Ref.
YS 4 (44.4) 6 (10.9) 2.08 (0.02, 227.79)
Heart beat 5 (55.5) 48 (87.3) 0.34 (0.00, 34.25)
Abdominal pain due to ectopic site rupture 1 (11.1) 18 (32.7) .260 0.26 (0.03, 2.21)
Heterotopic pregnancy type .760
Right tubal pregnancy 2 (22.2) 20 (36.4) Ref.
Left tubal pregnancy 5 (55.6) 21 (38.2) 2.10 (0.40, 10.89)
Bilateral tubal pregnancy 0 1 (1.8) 2.73 (0.02, 306.96)
Right cornual pregnancy 2 (22.2) 6 (10.9) 3.15 (0.41, 24.46)
Left cornual pregnancy 0 2 (3.6) 1.64 (0.03, 85.49)
Cesarean section scar pregnancy 0 1 (1.8) 2.73 (0.02, 306.96)
Left ovarian pregnancy 0 4 (7.3) 0.91 (0.03, 31.14)
Gestational age at treatment (mean) 5.97±0.50 6.80±1.04 .008 0.22 (0.66, 0.78)
Treatment method .683
Observation 1 (11.1) 1 (1.8) Ref.
Laparoscopic salpingectomy 7 (77.8) 40 (72.7) 0.19 (0.01, 3.30)
Exploratory salpingectomy 0 1 (1.8) 0.33 (0.00, 67.29)
Laparoscopic cornual resection 1 (11.1) 4 (7.3) 0.33 (0.01, 10.32)
US-guided KCL injection 0 4 (7.3) 0.11 (0.00, 8.06)
US-guided GS aspiration 0 1 (1.8) 0.33 (0.00, 67.29)
Laparoscopic excision of an ovarian mass 0 4 (7.3) 0.11 (0.00, 8.06)
Operation time, min 36.13±11.90 40.46±15.11 .441 0.98 (0.93, 1.03)
Anesthesia time, min 63.75±12.46 63.44±20.01 .967 1.00 (0.96, 1.04)
Progesterone supplement after treatment 8 (88.9) 51 (92.7) .415 0.63 (0.06, 6.35)
BMI=body mass index, CI=conﬁdence interval, COH-TI=controlled ovarian hyperstimulation and timed intercourse, GS=gestational sac, IUI= intrauterine insemination, IUP= intrauterine pregnancy, IVF= in
vitro fertilization, KCL=potassium chloride, OR=odds ratio, US=ultrasound, YS= yolk sac.
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the presence of ovarian EP if symptoms are not present.
Moreover, ovarian EP is rare, and it is not easy to distinguish
ovarian pregnancy from a corpus luteum via ultrasonography,
owing to echogenic similarities between them. If ovarian EP is
diagnosed late, an IUP may progress to advanced gestation
without loss of pregnancy, because advanced-gestation fetuses
with fetal heart activity have a lower possibility of being aborted.
The risk factors for miscarriage in our study were different
from those in other reports. Previous studies indicated that earlier
symptoms before diagnosis, such as abdominal pain or vaginal
bleeding, and later treatment of HP were independent predictors
of early pregnancy loss.[3,5] A recent study found that abdominal
pain before HP was diagnosed was an independent risk factor for
miscarriage in those with an HP.[7] However, we found that the
symptoms of abdominal pain and hemoperitoneum due to
rupture of the EP site did not affect the prognosis of patients with
an IUP. Additionally, our study showed that the GA at treatment
was earlier in the miscarriage group than it was in the
nonmiscarriage group. There were more patients with a normal
pregnancy with fetal heart activity in the nonmiscarriage group5than in the miscarriage group. This is possibly because a fetus
with a later GA could endure more difﬁculties, such as operative
and anesthetic circumferences, and fetuses with an advanced GA
might enter the stable stage.
In our study, the EP locations did not appear to be a risk factor
of miscarriage of an IUP fetus after HP was managed. A cesarean
section scar HP and bilateral tubal HP without symptoms were
determined via routinely performed TVS at 5.3 and 6.1 weeks of
gestation, respectively. A cesarean section scar HP is relatively
easy to diagnose with TVS; therefore, early diagnosis might be
possible. However, 1 patient with a cesarean section scar EP
spontaneously miscarried without treatment, and her IUP
progressed to advanced gestation, without losing the fetus.
If the patient is hemodynamically stable and does not have
abdominal pain, expectant management might be considered.We
managed these patients with just one session of treatment,
without further injection of medicine or surgery in any patient.
Several studies reported that HP with a local injection of MTX or
KCL or combined use of MTX and KCL at the EP site led to the
delivery of healthy babies,[8–10] although most reports were
small-sized case reports. However, the use of MTX should be
Na et al. Medicine (2018) 97:37 Medicineavoided due to MTX-related teratogenicity. Case reports of
MTX exposure after the misdiagnosis of EP have proven that
MTX embryopathy can appear due to early exposure to
MTX.[11]
In our study, the surgical treatments of HP were mostly
laparoscopic. Compared with open laparotomy, in laparoscopy,
general anesthesia and high intraabdominal carbon dioxide
pressure from the pneumoperitoneum can be harmful during
early pregnancy. High intraabdominal pressure can cause uterine
contraction and result in fetal loss. Therefore, short operation
and anesthesia times and low intraabdominal pressure during
surgery have been highlighted. However, laparoscopy can
provide better visualization and exposure, early return of bowel
function, less postoperative pain, and early ambulation.
Therefore, laparoscopic surgery takes precedence over open
laparotomy in pregnant women who require surgery. Several
previous studies proved that laparoscopic surgery is now as safe
as open surgery during pregnancy, with no deleterious effects on
either the mother or child.[7,12]
The incidences of ovarian EP and bilateral EP are very low. The
incidence of ovarian EP in those with natural conception ranges
from 1 in 2100 to 1 in 7000 pregnancies and accounts for 3% of
all EPs.[13] Spontaneous, bilateral, tubal EP has an estimated
incidence of 1 in 725 to 1 in 1580 EPs or 1 of 200,000
pregnancies.[14,15] Since pregnancy via ART increases the risk of
HP, a thorough ultrasonographic examination should be
performed in patients who become pregnant via ART, paying
attention to the number of embryos that are transferred during
IVF-conceived pregnancy. After pregnancy is conﬁrmed using the
hCG level, patients should be warned about the possibility of HP
even if routinely scheduled TVS appears to be normal. A short-
term ultrasonographic examination is required in patients where
HP was overlooked before the EP ruptures.
Previous studies showed miscarriage rates of 6% to 33% and
live birth rates of 53% to 93% after the treatment of an HP.[5]
The miscarriage rate in our study was similar to that in previous
reports. Furthermore, early, spontaneous abortion occurs in 10%
to 25% of all pregnancies.[16] The treatment of HP in early
pregnancy can be considered safe because there were no
signiﬁcant differences in the miscarriage rates of HP and normal
pregnancies between our study and previous studies.
The limitation of this study is that it is a retrospective
study with a small sample size. A randomized clinical trial on a
larger scale is ideal and necessary to validate the ﬁndings of this
study. In general, however, the incidence of HP is very low.
Therefore, it is difﬁcult to perform a randomized clinical trial
with a large sample size.
In conclusion, the early diagnosis and treatment of HP are
crucial to prevent maternal life-threatening conditions. GA at
treatment was the only independent risk factor for miscarriage in
patients with HP regardless of treatment methods. When patients
are diagnosed with an HP, most of pregnant women have
extreme anxiety. Therefore, our ﬁndings would be useful when
counseling patients before treatment.6Author contributions
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